Skip to main content

FENC

Fennec Pharmaceuticals Inc.
$10.70 +0.36 (+3.48%) At close · Jul 2
Market Cap
$371.69M
Shares
34,737,030

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-05-19 H.C. WAINWRIGHT 4TH ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ Conference
2026-05-14 FENNEC PHARMACEUTICALS Q1 2026 CONFERENCE CALL Conference
2026-03-24 FENNEC PHARMACEUTICALS Q4 2025 CONFERENCE CALL Conference
2025-12-03 PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE Conference
2025-09-09 H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE Conference
2025-08-14 FENNEC PHARMACEUTICALS Q2 2025 CONFERENCE CALL Conference
2025-05-20 H.C. WAINWRIGHT 3RD ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ Conference
2025-05-13 FENNEC PHARMACEUTICALS Q1 2025 CONFERENCE CALL Conference
2025-03-10 FENNEC PHARMACEUTICALS Q4 2024 CONFERENCE CALL Conference
2024-12-16 HCW @ HOME WITH FENNEC PHARMACEUTICALS INC. Event
2024-11-07 FENNEC PHARMACEUTICALS Q3 2024 CONFERENCE CALL Conference
2024-09-19 CANTOR GLOBAL HEALTHCARE CONFERENCE Conference
2024-09-11 H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE Conference
2024-08-13 FENNEC PHARMACEUTICALS Q2 2024 CONFERENCE CALL Conference
2024-05-14 FENNEC PHARMACEUTICALS Q1 2024 CONFERENCE CALL Conference
2024-03-21 FENNEC PHARMACEUTICALS Q4 2023 CONFERENCE CALL Conference
2023-11-16 JEFFERIES LONDON HEALTHCARE CONFERENCE Conference
2023-11-16 CRAIG HALLUM ALPHA SELECT CONFERENCE Conference
2023-11-06 FENNEC PHARMACEUTICALS Q3 2023 CONFERENCE CALL Conference
2023-09-27 CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE Conference
2023-08-03 FENNEC PHARMACEUTICALS Q2 2023 CONFERENCE CALL Conference
2023-05-11 FENNEC PHARMA Q1 2023 EARNINGS CALL Earnings call
2022-06-15 JMP SECURITIES LIFE SCIENCES CONFERENCE Conference

Source: https://investors.fennecpharma.com/

Key facts CIK 1211583 CUSIP 31447P100 13F (30d) 2 filings 2 filers Visit website Investor relations